Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Public Health Wales currently have Seegene platforms which are essential in providing a core part of NHS Wales COVID and respiratory testing, multiplex testing that includes Flu A, Flu B, RSV and SARS-CoV-2 and provide the largest multiplex testing capacity. The consumables included in this contract are essential for completing this testing and would have a significant impact on the service if not awarded.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Mast Group Ltd | - | £2,787,316 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £2,787,316 initial term | 1 single bid — no competition | Mast Group Ltd | active |
Weightings from the notice.